Share Price and Basic Stock Data
Last Updated: February 6, 2026, 2:47 pm
| PEG Ratio | -3.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
GHCL Ltd operates within the chemicals sector, focusing on inorganic products such as caustic soda and soda ash. The company’s market capitalization stood at ₹4,734 Cr, with its shares trading at ₹515. Over the past fiscal year, GHCL reported a significant revenue increase, with total sales for the year ending March 2023 reaching ₹4,551 Cr, up from ₹3,052 Cr in March 2022. However, sales have shown a declining trend in recent quarters, with ₹1,381 Cr in sales for September 2022 dropping to ₹805 Cr by September 2023. This decline is concerning, particularly as the company reported ₹798 Cr in sales for December 2023, indicating a continuous downward trajectory. The trailing twelve months (TTM) sales stood at ₹3,077 Cr, reflecting the challenges in maintaining consistent revenue growth amidst fluctuating market demand.
Profitability and Efficiency Metrics
GHCL’s profitability metrics reveal a mixed performance. The company reported a net profit of ₹570 Cr for the trailing twelve months, translating to an earnings per share (EPS) of ₹59.39. Operating profit margins (OPM) have fluctuated, reported at 22% for the fiscal year ending March 2023, but declining to 19% in December 2023. The interest coverage ratio, an indicator of financial health, stood at an impressive 59.78x, showcasing the company’s ability to meet interest obligations comfortably. However, the cash conversion cycle (CCC) lengthened to 183 days, indicating inefficiencies in managing working capital. This is further compounded by rising inventory days, which stood at 217 days for March 2025, suggesting potential challenges in inventory management. The company’s return on equity (ROE) stood at 18.6%, reflecting reasonable profitability relative to shareholder equity.
Balance Sheet Strength and Financial Ratios
GHCL’s balance sheet exhibits a robust financial structure, characterized by total borrowings of only ₹97 Cr against reserves of ₹3,540 Cr, implying a low debt-to-equity ratio of 0.02. This positions the company favorably within the industry, as it maintains a conservative financial leverage strategy. The current ratio, reported at 5.31x, indicates strong liquidity, ensuring that the company can cover short-term liabilities comfortably. Additionally, GHCL’s book value per share, which stood at ₹364.37 as of March 2025, reflects a solid asset backing for shareholders. However, the company faces challenges, as the net profit margin declined to 19.60% for March 2025, down from 25.11% in March 2023, suggesting pressures on profitability. The return on capital employed (ROCE) of 24.2% remains a highlight, showcasing effective use of capital for generating profits.
Shareholding Pattern and Investor Confidence
GHCL’s shareholding structure indicates a diversified ownership base, with promoters holding 18.97% and foreign institutional investors (FIIs) at 25.67%, reflecting substantial institutional interest. Domestic institutional investors (DIIs) account for 10.52%, while the public holds 44.82%. The number of shareholders has grown steadily, reaching 96,988 as of September 2025, suggesting increasing investor confidence in the company. However, the gradual decline in promoter holding from 19.05% in December 2022 to 18.97% raises questions about the commitment of the founding shareholders. The stability of foreign institutional investments is a positive indicator, as FIIs increased their stake from 24.38% in December 2022 to 26.41% in June 2025. This trend may enhance market confidence in GHCL’s long-term prospects, provided the company addresses its operational challenges effectively.
Outlook, Risks, and Final Insight
GHCL’s outlook hinges on its ability to navigate declining sales and profitability trends while leveraging its strong balance sheet to invest in operational efficiencies. The company’s low debt levels and high liquidity position provide a solid foundation for potential growth initiatives. However, risks include ongoing market volatility and potential supply chain disruptions, which could further impact sales and profitability. Additionally, the lengthening cash conversion cycle may indicate operational inefficiencies that need addressing. Looking ahead, GHCL has opportunities to enhance its market position by focusing on cost management and optimizing inventory control. If the company can stabilize its revenue and improve its operational metrics, it may regain investor confidence and enhance shareholder value. Conversely, failure to address these operational challenges could lead to continued pressure on profit margins and overall performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Caprolactam Chemicals Ltd | 32.1 Cr. | 69.7 | 81.0/37.5 | 3,207 | 11.6 | 0.00 % | 0.48 % | 13.7 % | 10.0 |
| Standard Industries Ltd | 102 Cr. | 15.9 | 26.7/13.0 | 20.4 | 0.00 % | 7.81 % | 10.5 % | 5.00 | |
| Gujarat Alkalies & Chemicals Ltd | 3,455 Cr. | 470 | 700/418 | 23,031 | 759 | 3.34 % | 0.34 % | 1.13 % | 10.0 |
| GHCL Ltd | 4,719 Cr. | 513 | 714/500 | 9.31 | 396 | 2.33 % | 24.2 % | 18.6 % | 10.0 |
| Tata Chemicals Ltd | 17,940 Cr. | 704 | 1,027/692 | 66.0 | 877 | 1.51 % | 3.96 % | 1.20 % | 10.0 |
| Industry Average | 5,357.00 Cr | 361.43 | 5,274.20 | 392.00 | 1.25% | 7.11% | 8.14% | 9.17 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,102 | 1,120 | 1,019 | 805 | 798 | 823 | 830 | 793 | 779 | 781 | 796 | 721 | 757 |
| Expenses | 735 | 771 | 719 | 592 | 648 | 639 | 614 | 582 | 549 | 563 | 599 | 564 | 598 |
| Operating Profit | 367 | 349 | 299 | 213 | 150 | 184 | 217 | 211 | 230 | 218 | 197 | 157 | 159 |
| OPM % | 33% | 31% | 29% | 26% | 19% | 22% | 26% | 27% | 30% | 28% | 25% | 22% | 21% |
| Other Income | 4 | -3 | 230 | 11 | 14 | 17 | 18 | 17 | 29 | 23 | 27 | 17 | 16 |
| Interest | 10 | 10 | 8 | 7 | 6 | 5 | 4 | 4 | 4 | 4 | 2 | 2 | 3 |
| Depreciation | 22 | 27 | 24 | 26 | 26 | 26 | 27 | 28 | 28 | 28 | 27 | 28 | 29 |
| Profit before tax | 339 | 309 | 497 | 191 | 133 | 170 | 203 | 196 | 227 | 209 | 195 | 145 | 143 |
| Tax % | 26% | 27% | 14% | 25% | 25% | 26% | 26% | 21% | 26% | 28% | 26% | 26% | 26% |
| Net Profit | 252 | 227 | 426 | 143 | 100 | 125 | 151 | 155 | 168 | 150 | 144 | 107 | 106 |
| EPS in Rs | 26.38 | 23.70 | 44.60 | 14.94 | 10.43 | 13.04 | 15.73 | 16.17 | 17.59 | 15.69 | 15.00 | 11.11 | 11.53 |
Last Updated: February 5, 2026, 10:40 pm
Below is a detailed analysis of the quarterly data for GHCL Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 757.00 Cr.. The value appears strong and on an upward trend. It has increased from 721.00 Cr. (Sep 2025) to 757.00 Cr., marking an increase of 36.00 Cr..
- For Expenses, as of Dec 2025, the value is 598.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 564.00 Cr. (Sep 2025) to 598.00 Cr., marking an increase of 34.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 157.00 Cr. (Sep 2025) to 159.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Dec 2025, the value is 21.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Sep 2025) to 21.00%, marking a decrease of 1.00%.
- For Other Income, as of Dec 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Sep 2025) to 16.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Dec 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Dec 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Sep 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 143.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Sep 2025) to 143.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Dec 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 26.00%.
- For Net Profit, as of Dec 2025, the value is 106.00 Cr.. The value appears to be declining and may need further review. It has decreased from 107.00 Cr. (Sep 2025) to 106.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 11.53. The value appears strong and on an upward trend. It has increased from 11.11 (Sep 2025) to 11.53, marking an increase of 0.42.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:20 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,201 | 2,356 | 2,531 | 2,784 | 2,919 | 3,341 | 3,305 | 2,491 | 3,052 | 4,551 | 3,447 | 3,183 | 3,077 |
| Expenses | 1,767 | 1,828 | 1,901 | 2,103 | 2,313 | 2,582 | 2,576 | 1,886 | 2,322 | 3,048 | 2,596 | 2,306 | 2,275 |
| Operating Profit | 434 | 528 | 629 | 681 | 607 | 759 | 729 | 605 | 730 | 1,503 | 851 | 877 | 803 |
| OPM % | 20% | 22% | 25% | 24% | 21% | 23% | 22% | 24% | 24% | 33% | 25% | 28% | 26% |
| Other Income | -26 | -15 | -3 | 37 | 38 | 16 | 16 | 18 | 211 | 119 | 270 | 88 | 96 |
| Interest | 183 | 171 | 165 | 137 | 127 | 127 | 120 | 74 | 51 | 39 | 27 | 17 | 12 |
| Depreciation | 82 | 85 | 82 | 86 | 110 | 117 | 131 | 111 | 87 | 94 | 102 | 112 | 111 |
| Profit before tax | 143 | 257 | 380 | 495 | 407 | 531 | 495 | 437 | 802 | 1,489 | 991 | 836 | 776 |
| Tax % | 24% | 29% | 32% | 23% | 13% | 34% | 20% | 25% | 19% | 23% | 20% | 25% | |
| Net Profit | 109 | 182 | 258 | 380 | 356 | 351 | 397 | 326 | 650 | 1,142 | 794 | 624 | 570 |
| EPS in Rs | 10.85 | 18.19 | 25.78 | 38.04 | 36.59 | 35.77 | 41.75 | 34.33 | 68.14 | 119.41 | 82.94 | 65.18 | 59.39 |
| Dividend Payout % | 18% | 12% | 0% | 13% | 14% | 14% | 7% | 16% | 22% | 15% | 14% | 18% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 66.97% | 41.76% | 47.29% | -6.32% | -1.40% | 13.11% | -17.88% | 99.39% | 75.69% | -30.47% | -21.41% |
| Change in YoY Net Profit Growth (%) | 0.00% | -25.21% | 5.53% | -53.60% | 4.91% | 14.51% | -30.99% | 117.27% | -23.69% | -106.17% | 9.06% |
GHCL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -1% |
| 3 Years: | 1% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | -3% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 30% |
| 3 Years: | -1% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 22% |
| 3 Years: | 23% |
| Last Year: | 19% |
Last Updated: September 5, 2025, 4:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:17 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 100 | 100 | 100 | 99 | 97 | 98 | 95 | 95 | 95 | 96 | 96 | 96 | 96 |
| Reserves | 487 | 670 | 936 | 1,247 | 1,513 | 1,827 | 2,054 | 2,389 | 2,852 | 3,860 | 2,883 | 3,393 | 3,540 |
| Borrowings | 1,486 | 1,324 | 1,365 | 1,463 | 1,322 | 1,302 | 1,254 | 782 | 788 | 361 | 210 | 119 | 97 |
| Other Liabilities | 941 | 758 | 548 | 694 | 695 | 767 | 766 | 712 | 1,261 | 816 | 581 | 578 | 540 |
| Total Liabilities | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,272 |
| Fixed Assets | 1,869 | 1,934 | 2,049 | 2,410 | 2,502 | 2,591 | 2,664 | 2,675 | 2,474 | 1,731 | 1,842 | 1,844 | 1,842 |
| CWIP | 12 | 7 | 37 | 26 | 74 | 117 | 122 | 81 | 213 | 109 | 55 | 256 | 370 |
| Investments | 7 | 2 | 15 | 9 | 10 | 12 | 9 | 15 | 17 | 380 | 420 | 651 | 831 |
| Other Assets | 1,125 | 909 | 848 | 1,059 | 1,043 | 1,275 | 1,375 | 1,207 | 2,292 | 2,914 | 1,453 | 1,435 | 1,229 |
| Total Assets | 3,014 | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,272 |
Below is a detailed analysis of the balance sheet data for GHCL Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 96.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 96.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,540.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,393.00 Cr. (Mar 2025) to 3,540.00 Cr., marking an increase of 147.00 Cr..
- For Borrowings, as of Sep 2025, the value is 97.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 119.00 Cr. (Mar 2025) to 97.00 Cr., marking a decrease of 22.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 540.00 Cr.. The value appears to be improving (decreasing). It has decreased from 578.00 Cr. (Mar 2025) to 540.00 Cr., marking a decrease of 38.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,272.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,185.00 Cr. (Mar 2025) to 4,272.00 Cr., marking an increase of 87.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,842.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,844.00 Cr. (Mar 2025) to 1,842.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 370.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 370.00 Cr., marking an increase of 114.00 Cr..
- For Investments, as of Sep 2025, the value is 831.00 Cr.. The value appears strong and on an upward trend. It has increased from 651.00 Cr. (Mar 2025) to 831.00 Cr., marking an increase of 180.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,229.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,435.00 Cr. (Mar 2025) to 1,229.00 Cr., marking a decrease of 206.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,272.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,185.00 Cr. (Mar 2025) to 4,272.00 Cr., marking an increase of 87.00 Cr..
Notably, the Reserves (3,540.00 Cr.) exceed the Borrowings (97.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 433.00 | 527.00 | 628.00 | 680.00 | 606.00 | 758.00 | 728.00 | -177.00 | -58.00 | -360.00 | 641.00 | 758.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 38 | 26 | 36 | 29 | 32 | 30 | 33 | 27 | 18 | 19 | 24 |
| Inventory Days | 227 | 193 | 194 | 187 | 182 | 199 | 198 | 245 | 294 | 177 | 185 | 217 |
| Days Payable | 233 | 155 | 110 | 107 | 109 | 106 | 102 | 121 | 107 | 53 | 55 | 57 |
| Cash Conversion Cycle | 57 | 76 | 110 | 117 | 101 | 125 | 126 | 158 | 214 | 142 | 149 | 183 |
| Working Capital Days | -52 | -39 | -48 | -30 | -12 | 10 | 26 | 61 | 87 | 50 | 50 | 58 |
| ROCE % | 17% | 22% | 25% | 24% | 19% | 21% | 19% | 16% | 19% | 36% | 21% | 24% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 2,273,226 | 0.76 | 128.37 | 2,600,000 | 2026-01-26 05:28:27 | -12.57% |
| DSP ELSS Tax Saver Fund | 1,265,155 | 0.41 | 71.44 | 1,447,019 | 2026-01-26 05:28:27 | -12.57% |
| Franklin India Small Cap Fund | 1,159,493 | 0.49 | 65.48 | 1,449,472 | 2026-01-26 05:28:27 | -20.01% |
| UTI Large & Mid Cap Fund | 687,849 | 0.69 | 38.84 | 733,571 | 2026-01-26 05:28:27 | -6.23% |
| UTI Aggressive Hybrid Fund | 631,183 | 0.53 | 35.64 | 670,600 | 2026-01-26 05:28:27 | -5.88% |
| ICICI Prudential Smallcap Fund | 396,420 | 0.27 | 22.39 | 850,000 | 2026-01-26 05:28:27 | -53.36% |
| HDFC Dividend Yield Fund | 369,983 | 0.34 | 20.89 | 400,000 | 2026-01-26 05:28:27 | -7.5% |
| UTI Retirement Fund | 187,658 | 0.22 | 10.6 | 206,972 | 2026-01-26 05:28:27 | -9.33% |
| Mahindra Manulife Flexi Cap Fund | 55,455 | 0.2 | 3.13 | 147,361 | 2026-01-26 05:28:27 | -62.37% |
| Mahindra Manulife ELSS Tax Saver Fund | 25,456 | 0.15 | 1.44 | 85,000 | 2026-01-26 05:28:27 | -70.05% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 65.50 | 83.43 | 120.06 | 67.89 | 34.32 |
| Diluted EPS (Rs.) | 65.34 | 83.33 | 120.06 | 67.89 | 34.23 |
| Cash EPS (Rs.) | 76.83 | 93.61 | 129.28 | 80.36 | 48.37 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 364.37 | 311.17 | 413.83 | 324.73 | 261.47 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 364.37 | 311.17 | 413.83 | 324.73 | 261.47 |
| Revenue From Operations / Share (Rs.) | 332.48 | 360.06 | 475.51 | 397.68 | 305.24 |
| PBDIT / Share (Rs.) | 100.65 | 94.00 | 159.03 | 104.32 | 69.80 |
| PBIT / Share (Rs.) | 89.00 | 83.33 | 149.17 | 92.03 | 55.76 |
| PBT / Share (Rs.) | 87.32 | 103.58 | 153.05 | 85.34 | 46.16 |
| Net Profit / Share (Rs.) | 65.19 | 82.94 | 119.42 | 68.07 | 34.32 |
| NP After MI And SOA / Share (Rs.) | 65.19 | 82.94 | 119.42 | 68.07 | 34.32 |
| PBDIT Margin (%) | 30.27 | 26.10 | 33.44 | 26.23 | 22.86 |
| PBIT Margin (%) | 26.76 | 23.14 | 31.37 | 23.14 | 18.26 |
| PBT Margin (%) | 26.26 | 28.76 | 32.18 | 21.45 | 15.12 |
| Net Profit Margin (%) | 19.60 | 23.03 | 25.11 | 17.11 | 11.24 |
| NP After MI And SOA Margin (%) | 19.60 | 23.03 | 25.11 | 17.11 | 11.24 |
| Return on Networth / Equity (%) | 17.88 | 26.65 | 28.85 | 20.96 | 13.12 |
| Return on Capital Employeed (%) | 22.32 | 23.76 | 31.97 | 22.97 | 15.93 |
| Return On Assets (%) | 14.91 | 21.06 | 22.23 | 12.94 | 8.19 |
| Long Term Debt / Equity (X) | 0.01 | 0.03 | 0.06 | 0.13 | 0.22 |
| Total Debt / Equity (X) | 0.02 | 0.06 | 0.08 | 0.24 | 0.24 |
| Asset Turnover Ratio (%) | 0.80 | 0.77 | 0.89 | 0.84 | 0.69 |
| Current Ratio (X) | 5.31 | 4.30 | 4.69 | 1.82 | 1.71 |
| Quick Ratio (X) | 3.61 | 2.73 | 3.54 | 1.03 | 0.53 |
| Inventory Turnover Ratio (X) | 4.99 | 1.55 | 1.49 | 1.75 | 1.48 |
| Dividend Payout Ratio (NP) (%) | 18.32 | 20.96 | 12.49 | 8.08 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.54 | 18.57 | 11.54 | 6.84 | 0.00 |
| Earning Retention Ratio (%) | 81.68 | 79.04 | 87.51 | 91.92 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.46 | 81.43 | 88.46 | 93.16 | 0.00 |
| Interest Coverage Ratio (X) | 59.78 | 35.33 | 39.31 | 15.59 | 7.27 |
| Interest Coverage Ratio (Post Tax) (X) | 39.72 | 23.56 | 27.90 | 10.41 | 4.58 |
| Enterprise Value (Cr.) | 5531.62 | 3948.48 | 5021.66 | 5717.82 | 2744.15 |
| EV / Net Operating Revenue (X) | 1.74 | 1.15 | 1.10 | 1.51 | 0.94 |
| EV / EBITDA (X) | 5.74 | 4.39 | 3.30 | 5.77 | 4.14 |
| MarketCap / Net Operating Revenue (X) | 1.85 | 1.23 | 1.06 | 1.38 | 0.75 |
| Retention Ratios (%) | 81.67 | 79.03 | 87.50 | 91.91 | 0.00 |
| Price / BV (X) | 1.69 | 1.42 | 1.22 | 1.69 | 0.88 |
| Price / Net Operating Revenue (X) | 1.85 | 1.23 | 1.06 | 1.38 | 0.75 |
| EarningsYield | 0.10 | 0.18 | 0.23 | 0.12 | 0.14 |
After reviewing the key financial ratios for GHCL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 65.50. This value is within the healthy range. It has decreased from 83.43 (Mar 24) to 65.50, marking a decrease of 17.93.
- For Diluted EPS (Rs.), as of Mar 25, the value is 65.34. This value is within the healthy range. It has decreased from 83.33 (Mar 24) to 65.34, marking a decrease of 17.99.
- For Cash EPS (Rs.), as of Mar 25, the value is 76.83. This value is within the healthy range. It has decreased from 93.61 (Mar 24) to 76.83, marking a decrease of 16.78.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.37. It has increased from 311.17 (Mar 24) to 364.37, marking an increase of 53.20.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 364.37. It has increased from 311.17 (Mar 24) to 364.37, marking an increase of 53.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 332.48. It has decreased from 360.06 (Mar 24) to 332.48, marking a decrease of 27.58.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 100.65. This value is within the healthy range. It has increased from 94.00 (Mar 24) to 100.65, marking an increase of 6.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 89.00. This value is within the healthy range. It has increased from 83.33 (Mar 24) to 89.00, marking an increase of 5.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 87.32. This value is within the healthy range. It has decreased from 103.58 (Mar 24) to 87.32, marking a decrease of 16.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 65.19. This value is within the healthy range. It has decreased from 82.94 (Mar 24) to 65.19, marking a decrease of 17.75.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 65.19. This value is within the healthy range. It has decreased from 82.94 (Mar 24) to 65.19, marking a decrease of 17.75.
- For PBDIT Margin (%), as of Mar 25, the value is 30.27. This value is within the healthy range. It has increased from 26.10 (Mar 24) to 30.27, marking an increase of 4.17.
- For PBIT Margin (%), as of Mar 25, the value is 26.76. This value exceeds the healthy maximum of 20. It has increased from 23.14 (Mar 24) to 26.76, marking an increase of 3.62.
- For PBT Margin (%), as of Mar 25, the value is 26.26. This value is within the healthy range. It has decreased from 28.76 (Mar 24) to 26.26, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 19.60. This value exceeds the healthy maximum of 10. It has decreased from 23.03 (Mar 24) to 19.60, marking a decrease of 3.43.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.60. This value is within the healthy range. It has decreased from 23.03 (Mar 24) to 19.60, marking a decrease of 3.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 26.65 (Mar 24) to 17.88, marking a decrease of 8.77.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.32. This value is within the healthy range. It has decreased from 23.76 (Mar 24) to 22.32, marking a decrease of 1.44.
- For Return On Assets (%), as of Mar 25, the value is 14.91. This value is within the healthy range. It has decreased from 21.06 (Mar 24) to 14.91, marking a decrease of 6.15.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.02, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.80. It has increased from 0.77 (Mar 24) to 0.80, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 5.31. This value exceeds the healthy maximum of 3. It has increased from 4.30 (Mar 24) to 5.31, marking an increase of 1.01.
- For Quick Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 2. It has increased from 2.73 (Mar 24) to 3.61, marking an increase of 0.88.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.99. This value is within the healthy range. It has increased from 1.55 (Mar 24) to 4.99, marking an increase of 3.44.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 18.32. This value is below the healthy minimum of 20. It has decreased from 20.96 (Mar 24) to 18.32, marking a decrease of 2.64.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.54. This value is below the healthy minimum of 20. It has decreased from 18.57 (Mar 24) to 15.54, marking a decrease of 3.03.
- For Earning Retention Ratio (%), as of Mar 25, the value is 81.68. This value exceeds the healthy maximum of 70. It has increased from 79.04 (Mar 24) to 81.68, marking an increase of 2.64.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.46. This value exceeds the healthy maximum of 70. It has increased from 81.43 (Mar 24) to 84.46, marking an increase of 3.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 59.78. This value is within the healthy range. It has increased from 35.33 (Mar 24) to 59.78, marking an increase of 24.45.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 39.72. This value is within the healthy range. It has increased from 23.56 (Mar 24) to 39.72, marking an increase of 16.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,531.62. It has increased from 3,948.48 (Mar 24) to 5,531.62, marking an increase of 1,583.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.74, marking an increase of 0.59.
- For EV / EBITDA (X), as of Mar 25, the value is 5.74. This value is within the healthy range. It has increased from 4.39 (Mar 24) to 5.74, marking an increase of 1.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.85, marking an increase of 0.62.
- For Retention Ratios (%), as of Mar 25, the value is 81.67. This value exceeds the healthy maximum of 70. It has increased from 79.03 (Mar 24) to 81.67, marking an increase of 2.64.
- For Price / BV (X), as of Mar 25, the value is 1.69. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.69, marking an increase of 0.27.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.85. This value is within the healthy range. It has increased from 1.23 (Mar 24) to 1.85, marking an increase of 0.62.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.18 (Mar 24) to 0.10, marking a decrease of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in GHCL Ltd:
- Net Profit Margin: 19.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.32% (Industry Average ROCE: 7.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.88% (Industry Average ROE: 8.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 39.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.61
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.31 (Industry average Stock P/E: 5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 19.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Caustic Soda/Soda Ash | GHCL House, Opp. Punjabi Hall, Ahmedabad Gujarat 380009 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anurag Dalmia | Non Executive Chairman |
| Mr. R S Jalan | Managing Director |
| Mr. Raman Chopra | Executive Director (Finance) & CFO |
| Mr. Neelabh Dalmia | Executive Director |
| Mrs. Vijaylaxmi Joshi | Independent Director |
| Dr. Manoj Vaish | Independent Director |
| Justice(Retd) Ravindra Singh | Independent Director |
| Mr. Arun Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of GHCL Ltd?
GHCL Ltd's intrinsic value (as of 06 February 2026) is ₹546.15 which is 6.46% higher the current market price of ₹513.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹4,719 Cr. market cap, FY2025-2026 high/low of ₹714/500, reserves of ₹3,540 Cr, and liabilities of ₹4,272 Cr.
What is the Market Cap of GHCL Ltd?
The Market Cap of GHCL Ltd is 4,719 Cr..
What is the current Stock Price of GHCL Ltd as on 06 February 2026?
The current stock price of GHCL Ltd as on 06 February 2026 is ₹513.
What is the High / Low of GHCL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of GHCL Ltd stocks is ₹714/500.
What is the Stock P/E of GHCL Ltd?
The Stock P/E of GHCL Ltd is 9.31.
What is the Book Value of GHCL Ltd?
The Book Value of GHCL Ltd is 396.
What is the Dividend Yield of GHCL Ltd?
The Dividend Yield of GHCL Ltd is 2.33 %.
What is the ROCE of GHCL Ltd?
The ROCE of GHCL Ltd is 24.2 %.
What is the ROE of GHCL Ltd?
The ROE of GHCL Ltd is 18.6 %.
What is the Face Value of GHCL Ltd?
The Face Value of GHCL Ltd is 10.0.